The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Benign prostatic hyperplasia – what do we know?
Open accessAbstract
Objectives: To present historical and contemporary hypotheses on the pathogenesis of benign prostatic hyperplasia (BPH), and the potential implications for current medical therapies. Methods: The literature on BPH was reviewed. BPH is a prevalent disease with significant health and economic impacts on patients and health organisations across the world, whilst the cause/initiation of the disease process has still not been fully determined. Results: In BPH, pathways involving androgens, oestrogens, insulin, inflammation, proliferative reawakening, stem cells and telomerase have been hypothesised in the pathogenesis of the disease. A number of pathways first described >40 years ago have been first rebuked and then have come back into favour. A system of an inflammatory process within the prostate, which leads to growth factor production, stem cell activation, and cellular proliferation encompassing a number of pathways, is currently in vogue. This review also highlights the physiology of the prostate cell subpopulations and how this may account for the delay/failure in treatment response for certain medical therapies. Conclusion: BPH is an important disease, and as the pathogenesis is not fully understood it impacts the effectiveness of medical therapies. This impacts patients, with further research potentially highlighting novel therapeutic avenues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Metformin inhibits the proliferation of benign prostatic epithelial cells
Wang, Z., Xiao, X., Ge, R., Li, J., Johnson, C. W., Rassoulian, C., & Olumi, A. F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173335 · Cited by 29
RetractedLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
The Development of Human Benign Prostatic Hyperplasia with Age
Berry, S. J., Coffey, D. S., Walsh, P. C., & Ewing, L. L. (1984) · Journal of Urology · doi:10.1016/s0022-5347(17)49698-4 · Cited by 2,488
Aromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., MAHENDROO, M. S., MEANS, G. D., KILGORE, M. W., HINSHELWOOD, M. M., GRAHAM-LORENCE, S., AMARNEH, B., ITO, Y., FISHER, C. R., MICHAEL, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,537
CD133, a novel marker for human prostatic epithelial stem cells
Richardson, G. D., Robson, C. N., Lang, S. H., Neal, D. E., Maitland, N. J., & Collins, A. T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01222 · Cited by 770
Self-citationInsulin-like Growth Factor Binding Proteins
Rechler, M. M. (1993) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60444-6 · Cited by 755
Etiology and disease process of benign prostatic hyperplasia
Isaacs, J. T., & Coffey, D. S. (1989) · The Prostate · doi:10.1002/pros.2990150506 · Cited by 558
Origin and evolution of benign prostatic enlargement.
McNeal, J. E. (1978) · PubMed · Cited by 539
Is Benign Prostatic Hyperplasia (BPH) an Immune Inflammatory Disease?
Kramer, G., Mitteregger, D., & Marberger, M. (2007) · European Urology · doi:10.1016/j.eururo.2006.12.011 · Cited by 464
Morgentaler, A., & Traish, A. M. (2009) · European Urology · doi:10.1016/j.eururo.2008.09.024 · Cited by 462
De Nunzio, C., Kramer, G., Marberger, M., Montironi, R., Nelson, W., Schröder, F., Sciarra, A., & Tubaro, A. (2011) · European Urology · doi:10.1016/j.eururo.2011.03.055 · Cited by 454
Dihydrotestosterone in prostatic hypertrophy
Siiteri, P. K., & Wilson, J. D. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106391 · Cited by 406
Pathology of benign prostatic hyperplasia. Insight into etiology.
McNeal, J. E. (1990) · PubMed · Cited by 334
Androgens and estrogens in benign prostatic hyperplasia: Past, present and future
Nicholson, T. M., & Ricke, W. A. (2011) · Differentiation · doi:10.1016/j.diff.2011.04.006 · Cited by 331
Speakman, M., Kirby, R., Doyle, S., & Ioannou, C. (2015) · BJU International · doi:10.1111/bju.12745 · Cited by 284
Regenerative potential of prostate luminal cells revealed by single-cell analysis
Karthaus, W. R., Hofree, M., Choi, D., Linton, E. L., Turkekul, M., Bejnood, A., Carver, B., Gopalan, A., Abida, W., Laudone, V., et al. (2020) · Science · doi:10.1126/science.aay0267 · Cited by 283
Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis
Robert, G., Descazeaud, A., Nicolaïew, N., Terry, S., Sirab, N., Vacherot, F., Maillé, P., Allory, Y., & de la Taille, A. (2009) · The Prostate · doi:10.1002/pros.21027 · Cited by 277
Lee, S. W. H., Chan, E. M. C., & Lai, Y. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-06628-8 · Cited by 254
Steiner, G. E., Newman, M. E., Paikl, D., Stix, U., Memaran‐Dagda, N., Lee, C., & Marberger, M. J. (2003) · The Prostate · doi:10.1002/pros.10238 · Cited by 238
Apoptotic versus proliferative activities in human benign prostatic hyperplasia
Kyprianou, N., Tu, H., & Jacobs, S. C. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90396-2 · Cited by 235
Multipotent and unipotent progenitors contribute to prostate postnatal development
Ousset, M., Van Keymeulen, A., Bouvencourt, G., Sharma, N., Achouri, Y., Simons, B. D., & Blanpain, C. (2012) · Nature Cell Biology · doi:10.1038/ncb2600 · Cited by 221
Estrogen and androgen signaling in the pathogenesis of BPH
Ho, C. K. M., & Habib, F. K. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2010.207 · Cited by 209
Wang, W., Bergh, A., & Damber, J. (2004) · The Prostate · doi:10.1002/pros.20061 · Cited by 204
McPherson, S. J., Hussain, S., Balanathan, P., Hedwards, S. L., Niranjan, B., Grant, M., Chandrasiri, U. P., Toivanen, R., Wang, Y., Taylor, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905524107 · Cited by 197
Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency
Imperato‐McGinley, J., Gautier, T., Zirinsky, K., Hom, T., Palomo, O., Stein, E. A., Vaughan, E. D., Markísz, J. A., de Arellano, E. R., & Kazam, E. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400866 · Cited by 184
Benign prostatic hyperplasia: a new metabolic disease?
Vignozzi, L., Rastrelli, G., Corona, G., Gacci, M., Forti, G., & Maggi, M. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0051-3 · Cited by 174
Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia
Nandeesha, H., Koner, B. C., Dorairajan, L. N., & Sen, S. K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.01.019 · Cited by 169
Lycopene Inhibits Disease Progression in Patients with Benign Prostate Hyperplasia
Schwarz, S., Obermüller-Jevic, U. C., Hellmis, E., Koch, W., Jacobi, G., & Biesalski, H.-K. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.1.49 · Cited by 159
Endocrine control of benign prostatic hyperplasia
Vignera, S. L., Condorelli, R. A., Russo, G. I., Morgia, G., & Calogero, A. E. (2016) · Andrology · doi:10.1111/andr.12186 · Cited by 155
Genetic Susceptibility of Benign Prostatic Hyperplasia
Sanda, M. G., Beaty, T. H., Stutzman, R. E., Childs, B., & Walsh, P. C. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32831-8 · Cited by 149
Textbook of Benign Prostatic Hyperplasia
Bosch, J. L. H. R., & Schroder, F. H. (1996) · BMJ · doi:10.1136/bmj.313.7056.567 · Cited by 137
Serum sex hormones and measures of benign prostatic hyperplasia
Roberts, R. O., Jacobson, D. J., Rhodes, T., Klee, G. G., Leiber, M. M., & Jacobsen, S. J. (2004) · The Prostate · doi:10.1002/pros.20080 · Cited by 136
Zhang, W., Kapusta, L. R., Slingerland, J. M., & Klotz, L. H. (1998) · PubMed · Cited by 130
Clemmons, D. R., & Maile, L. A. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0376 · Cited by 120
Review: Testosterone and the metabolic syndrome
Muraleedharan, V., & Jones, T. H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810390258 · Cited by 110
The Impact of Nocturia on Falls and Fractures: A Systematic Review and Meta-Analysis
Pesonen, J. S., Vernooij, R. W. M., Cartwright, R., Aoki, Y., Agarwal, A., Mangera, A., Markland, A. D., Tsui, J. F., Santti, H., Griebling, T. L., et al. (2019) · The Journal of Urology · doi:10.1097/ju.0000000000000459 · Cited by 108
Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates
Masai, M., Sumiya, H., Akimoto, S., Yatani, R., Chang, C., Liao, S., & Shimazaki, J. (1990) · The Prostate · doi:10.1002/pros.2990170405 · Cited by 91
Edwards, J. E., & Moore, R. A. (2002) · BMC Urology · doi:10.1186/1471-2490-2-14 · Cited by 88
Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology
Meeker, A. K. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.11.002 · Cited by 81
Giri, D., & Ittmann, M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64535-x · Cited by 71
Salam, M. T., Ursin, G., Skinner, E. C., Dessissa, T., & Reichardt, J. K. V. (2005) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2004.12.014 · Cited by 70
Mesenchymal stem cells and the embryonic reawakening theory of BPH
Brennen, W. N., & Isaacs, J. T. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0087-9 · Cited by 67
Epidemiology; diagnosis, and treatment of male hypogonadotropic hypogonadism
Lenzi, A., Balercia, G., Bellastella, A., Colao, A., Fabbri, A., Foresta, C., Galdiero, M., Gandini, L., Krausz, C., Lombardi, G., et al. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345775 · Cited by 65
NF‐κB and androgen receptor variant expression correlate with human BPH progression
Austin, D. C., Strand, D. W., Love, H. L., Franco, O. E., Jang, A., Grabowska, M. M., Miller, N. L., Hameed, O. M., Clark, P. E., Fowke, J. H., et al. (2015) · The Prostate · doi:10.1002/pros.23140 · Cited by 63
Stromally Expressed c-Jun Regulates Proliferation of Prostate Epithelial Cells
Li, W., Wu, C., Febbo, P. G., & Olumi, A. F. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070285 · Cited by 61
Incidence, prevalence and management of lower urinary tract symptoms in men in the UK
Logie, J. W., Clifford, G. M., & Farmer, R. D. T. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05339.x · Cited by 60
Eleazu, C. O., Eleazu, K. C., & Kalu, W. O. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00234 · Cited by 52
Sampson, N., Zenzmaier, C., Heitz, M., Hermann, M., Plas, E., Schäfer, G., Klocker, H., & Berger, P. (2013) · Endocrinology · doi:10.1210/en.2012-2259 · Cited by 51
Hellwege, J. N., Stallings, S., Torstenson, E. S., Carroll, R. J., Borthwick, K. M., Brilliant, M. H., Crosslin, D. R., GORDON, A. S., Hripcsak, G. M., Jarvik, G. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42427-z · Cited by 51
Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases
Ishiguro, H., & Kawahara, T. (2014) · BioMed Research International · doi:10.1155/2014/436123 · Cited by 48
Major Depression Drives Severity of American Urological Association Symptom Index
Johnson, T. V., Abbasi, A. A., Ehrlich, S. S., Kleris, R. S., Chirumamilla, S. L., Schoenberg, E. D., Owen‐Smith, A. A., Raison, C. L., & Master, V. A. (2010) · Urology · doi:10.1016/j.urology.2010.01.069 · Cited by 40
Hernandez, C. E., Estivill, E., Prieto, M., & Badia, X. C. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x280473 · Cited by 35
Graham, M. K., Kim, J. Y., Da, J., Brosnan‐Cashman, J. A., Rizzo, A. J., Valle, J. A. B.-D., Chia, L., Rubenstein, M., Davis, C., Zheng, Q., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0654 · Cited by 35
Rane, J. K., Greener, S., Frame, F. M., Mann, V. M., Simms, M. S., Collins, A. T., Berney, D. M., & Maitland, N. J. (2015) · European Urology · doi:10.1016/j.eururo.2015.09.039 · Cited by 22
Self-citationEerola, R., Piironen, T., Pettersson, K. S. I., Lövgren, J., Vehniäinen, M., Lilja, H. G., Dowell, B. L., Lövgren, T. N.-E., & Karp, M. T. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970501)31:2<118::aid-pros7>3.0.co;2-j · Cited by 22
Giri, A., Edwards, T. L., Motley, S. S., Byerly, S. H., & Fowke, J. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132028 · Cited by 19
Nomura, H., Kawashima, H., Masaki, S., Hosono, T. Y., Matsumura, K., Tamada, S., Tanaka, T., & Nakatani, T. (2009) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2009.20 · Cited by 18
Testosterone and the metabolic syndrome
Arver, S. (2008) · Journal of Men s Health · doi:10.1016/j.jomh.2008.03.009 · Cited by 13
Stem Cells in the Normal and Malignant Prostate
Maitland, N. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_1 · Cited by 9
Self-citationTraish, A. M. (2015) · Current Sexual Health Reports · doi:10.1007/s11930-015-0061-y · Cited by 2
Metadata
- Authors
- Devlin, C. M., Simms, M. S., & Maitland, N. J.
- Venue
- BJU International
- Publisher
- Wiley
- Published
- 2020-09-24
- Volume
- 127
- Issue
- 4
- Pages
- 389-399
- ISSN
- 1464-4096 (ISSN-L)
- 1464-410X
- OpenAlex
- W3084261092
- Cited by
- 287
- References
- 60
- FWCI
- 24.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.